5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked
MMW Fortschritte der Medizin 145(27-28): 58-59
2003
ISSN/ISBN: 1438-3276 PMID: 14587193 Document Number: 564681
Document emailed within 1 workday
Related Documents
Spivak, L.G.; Lokshin, K.L.; Vinarov, A.Z. 2015: Review of Clinical Studies on Combination Therapy of 5α-Reductase Inhibitors and Α1-Blockers in Patients with Benign Prostatic Hyperplasia Urologiia 2015(4): 125-133Zusman, R.M. 2000: The role of alpha 1-blockers in combination therapy for hypertension International Journal of Clinical Practice 54(1): 36-40
Bakinovskiĭ, L.V.; Gomtsian, A.R.; Baĭramova, N.E.; Kochetkov, N.K. 1985: Synthesis of oligosaccharide fragments of O-specific polysaccharides of Shigella flexneri. III. Synthesis of the tetrasaccharide Glc alpha 1-3Rha alpha 1-2(Glc alpha 1-3)Rha alpha 1-OMe and the pentasaccharide GlcNAc beta 1-2(Glc alpha 1-3)Rha alpha 1-2(Glc alpha 1-3)Rha alpha 1-OMe Bioorganicheskaia Khimiia 11(5): 655-661
Batzold, F.H. 1981: Approaches to prostatic 5 alpha-reductase inhibitors Progress in Clinical and Biological Research 75b: 269-282
Klotz, L.H. 2006: Androgen replacement and/or 5 alpha reductase inhibitors in aging men Canadian Journal of Urology 13(Suppl 1): 44-45
Djavan, B.; McConnell, J. 1996: The effect of 5-alpha-reductase inhibitors on benign prostatic hyperplasia Wiener Medizinische Wochenschrift 146(8): 165-168
Cohen, J.; Ooms, M.P.; Vreeburg, J.T. 1981: Reduction of fertilizing capacity of epididymal spermatozoa by 5 alpha-steroid reductase inhibitors Experientia 37(9): 1031-1032
Jaworska, L.; Rembiesa, R. 1982: Effect of delta 4-5 alpha-reductase inhibitors on progesterone 4-C-14 metabolism in the rat placenta in vitro Endokrynologia Polska 33(4-6): 183-191
Wu, J-Hui.; Sun, Z-Yue. 2013: Establishment of an in vitro screening model for steroid 5 alpha-reductase inhibitors with the microplate reader Zhonghua Nan Ke Xue 19(6): 483-486
Sun, Z.Y.; Tu, Z.H. 1998: A novel in vitro model to screen steroid 5 alpha-reductase inhibitors against benign prostatic hyperplasia Methods and Findings in Experimental and Clinical Pharmacology 20(4): 283-287
Jurincic-Winkler, C.; Horlbeck, R.; Klippel, K.F. 1993: Combination therapy with recombinant interferon alpha-21 (rIFN alpha 2a) and recombinant interleukin 2 (rIL-2) in metastatic renal cell cancer Wiener Klinische Wochenschrift 105(10): 271-276
Uhlén, S.; Porter, A.C.; Neubig, R.R. 1994: The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors Journal of Pharmacology and Experimental Therapeutics 271(3): 1558-1565
Stokes, G.S. 1988: Age-related effects of antihypertensive therapy with alpha-blockers Journal of Cardiovascular Pharmacology 12(Suppl 8): S109-S115
Lennert, K.A.; Hupe, H. 1973: Pre- and postoperative behavior of serum protein inhibitors alpha-2 macroglobulin and alpha-1 antitrypsin Die Medizinische Welt 24(22): 912-915
Tres, A.; Muñóz, J.R. 1977: Protease inhibitors, alpha-1-antitrypsin and alpha-2-macroglobulin, in liver processes Revista Clinica Espanola 145(6): 407-409
Grabowska-Bochenek, R.; Drózdz, M.; Kopieczna-Grzebieniak, E.; Piekarski, M. 1990: Concentration of some proteinase inhibitors: alpha 1-antitrypsin and alpha 2-macroglobulin in rabbit blood serum in two models of experimental atherosclerosis Acta Biochimica Polonica 37(1): 125-127
Jakobs, K.H. 1978: Synthetic alpha-adrenergic agonists are potent alpha-adrenergic blockers in human platelets Nature 274(5673): 819-820
Tsvetkova, I.V.; Karpova, E.A.; Voznyĭ, I.V.; Zolotukhina, T.V.; Biriukov, V.B.; Semiachkina, A.N. 1991: Use of 4-methylumbelliferryl-alpha-L-iduronide and 4-trifluoromethylumbelliferryl-alpha-L-iduronide for detecting alpha-L-iduronidase deficiencies in human tissue and for rapid prenatal diagnosis of Hurler disease Voprosy Meditsinskoi Khimii 37(1): 74-77
Destro, F. 1959: Preliminary studies of the use of 6-alpha-methyl-alpha-acetoxyprogesterone (M.A.P.) and 17-alpha-acetoxyprogesterone (A.P.) in gynecological and obstetrical therapy Minerva Ginecologica 11(6): 263-268
Takeda, M.; Takagi, T. 1980: Effects of a new bronchodilator, (alpha RS)-3-formamido-4-hydroxy-alpha-[[[(alpha RS)-p-methoxy-alpha-methylphenethyl] amino] methyl] benzyl alcohol fumarate dihydrate (BD 40A) on gastric acid secretion and gastrointestinal motility Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(3): 185-191